Tefavinca may be available in the countries listed below.
Ingredient matches for Tefavinca
Vincamine is reported as an ingredient of Tefavinca in the following countries:
- Spain
International Drug Name Search
Tefavinca may be available in the countries listed below.
Vincamine is reported as an ingredient of Tefavinca in the following countries:
International Drug Name Search
Primofenac may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Primofenac in the following countries:
International Drug Name Search
dif-THEER-ee-a AN-tee-tox-in
Available Dosage Forms:
Therapeutic Class: Antitoxin
Diphtheria antitoxin is used to prevent and/or treat diphtheria infection in persons exposed to the disease.
Although rare in the U.S., diphtheria is a serious disease that can cause life-threatening illnesses. Diphtheria is transmitted through contact with an infected person or a carrier of the disease.
Diphtheria antitoxin is to be administered only by or under the supervision of your doctor or other health care professional.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For diphtheria antitoxin, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to diphtheria antitoxin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Although there is no specific information comparing use of diphtheria antitoxin in children with use in other age groups, diphtheria antitoxin is not expected to cause different side effects or problems in children than it does in adults.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of diphtheria antitoxin in the elderly with use in other age groups. However, there is no evidence that the effects of diphtheria antitoxin in older adults differ from those in younger persons.
Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of diphtheria antitoxin. Make sure you tell your doctor if you have any other medical problems.
The dose of diphtheria antitoxin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of diphtheria antitoxin. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Flavobion may be available in the countries listed below.
Silibinin is reported as an ingredient of Flavobion in the following countries:
International Drug Name Search
Bupivacaina Clorhidrato may be available in the countries listed below.
Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacaina Clorhidrato in the following countries:
International Drug Name Search
Tremac may be available in the countries listed below.
Azithromycin is reported as an ingredient of Tremac in the following countries:
International Drug Name Search
UK matches:
Rec.INN
N05CD02
0000146-22-5
C15-H11-N3-O3
281
Antiepileptic agent
Benzodiazepine derivative
Hypnotic agent
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
SPC | Summary of Product Characteristics (UK) |
USAN | United States Adopted Name |
In the US, Totect (dexrazoxane systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Extravasation.
US matches:
Dexrazoxane is reported as an ingredient of Totect in the following countries:
Dexrazoxane hydrochloride (a derivative of Dexrazoxane) is reported as an ingredient of Totect in the following countries:
International Drug Name Search
Dromos may be available in the countries listed below.
Levocarnitine propionate hydrochloride (a derivative of Levocarnitine) is reported as an ingredient of Dromos in the following countries:
International Drug Name Search
Traumalix may be available in the countries listed below.
Etofenamate is reported as an ingredient of Traumalix in the following countries:
International Drug Name Search